Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Assets Average: 2014-2024

Historic Assets Average for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Dec 2024 value amounting to $1.5 billion.

  • Amphastar Pharmaceuticals' Assets Average rose 8.06% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 8.06%. This contributed to the annual value of $1.5 billion for FY2024, which is 37.05% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Assets Average stood at $1.5 billion for FY2024, which was up 37.05% from $1.1 billion recorded in FY2023.
  • Amphastar Pharmaceuticals' Assets Average's 5-year high stood at $1.5 billion during FY2024, with a 5-year trough of $609.1 million in FY2020.
  • In the last 3 years, Amphastar Pharmaceuticals' Assets Average had a median value of $1.1 billion in 2023 and averaged $1.1 billion.
  • Data for Amphastar Pharmaceuticals' Assets Average shows a peak YoY spiked of 59.52% (in 2023) over the last 5 years.
  • Amphastar Pharmaceuticals' Assets Average (Yearly) stood at $609.1 million in 2020, then climbed by 6.94% to $651.4 million in 2021, then rose by 8.50% to $706.8 million in 2022, then spiked by 59.52% to $1.1 billion in 2023, then spiked by 37.05% to $1.5 billion in 2024.